New Zealand Budget Outlook Shows Prolonged Deficits Despite Economic Recovery Hopes 
Asian Currencies Trade Sideways as Dollar Weakens Ahead of Key U.S. Data 
Silver Prices Hit Record High as Safe-Haven Demand Surges Amid U.S. Economic Uncertainty 
Asian Stocks Edge Higher as Tech Recovers, U.S. Economic Uncertainty Caps Gains 
U.S. Dollar Steadies Near October Lows as Rate Cut Expectations Keep Markets on Edge 
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing 
Australian Consumer Sentiment Slumps in Early December as Inflation Fears Resurface 
Asian Currencies Slip as Dollar Strengthens; Indian Rupee Rebounds on Intervention Hopes 
RBA Unlikely to Cut Interest Rates in 2026 as Inflation Pressures Persist, Says Westpac 
Asian Fund Managers Turn More Optimistic on Growth but Curb Equity Return Expectations: BofA Survey 
Dollar Holds Firm Ahead of Global Central Bank Decisions as Yen, Sterling and Euro React 
Singapore Growth Outlook Brightens for 2025 as Economists Flag AI and Geopolitical Risks 
Asian Stocks Slide as AI Valuation Fears and BOJ Uncertainty Weigh on Markets 
Oil Prices Climb on Venezuela Blockade, Russia Sanctions Fears, and Supply Risks 
South Korea Warns Weak Won Could Push Inflation Higher in 2025 
Bank of Japan Poised for Historic Rate Hike as Inflation Pressures Persist 
Starboard Value’s Investment in Kenvue Inc.
Activist hedge fund Starboard Value has taken a "sizeable" stake in Kenvue Inc., according to *The Wall Street Journal*. While the exact percentage of the investment is undisclosed, Starboard is pushing for changes aimed at boosting Kenvue's stock price. Kenvue, which was spun off from Johnson & Johnson in 2023, has seen its stock underperform both its industry peers and the broader market since its debut.
Kenvue’s Strong Consumer Brands
Kenvue boasts several well-known consumer brands, such as Tylenol, Listerine, and Band-Aid. Despite its strong portfolio, Kenvue's stock performance has been relatively muted in 2024, while the S&P 500 has surged by 24%. Starboard believes that these valuable brands are not yet reflected in the company’s current valuation.
Starboard’s Broader Strategy
This is not the first major move by Starboard Value. The hedge fund, led by CEO Jeff Smith, recently acquired a $1 billion stake in pharmaceutical giant Pfizer and has been involved in advocating for changes at tech companies like Salesforce, Autodesk, and Match Group.
